Eculizumab for the treatment of an atypical hemolytic uremic syndrome with mutations in complement factor I and C3

Statistics

Letter to the Editor

Eculizumab para el tratamiento de un síndrome urémico hemolítico atípico con mutaciones en los factores I y C3 del sistema del complemento

Emanuel Ferreiraa,

Corresponding author

emanuelfeferreira@gmail.com

Corresponding author at: Servicio de Nefrología, Centro Hospitalar e Universitário de Coimbra–Hospital Geral., Rua do Buxo, lote 17, 3040-792 Coimbra, Portugal. Tel.: +351 916699039.

, Nuno Oliveiraa, Maria Marquesa, Luís Franciscob, Ana Santosa, Armando Carreiraa, Mário Camposc

a Servicio de Nefrología, Centro Hospitalar e Universitário de Coimbra–Hospital Geral, Coimbra, Portugal

b Servicio de Hematología, Centro Hospitalar e Universitário de Coimbra–Hospital Geral, Coimbra, Portugal

c Servicio de Nefrología, Centro Hospitalar e Universitário de Coimbra–Hospitais da Universidade de Coimbra, Coimbra, Portugal

Read

9070

Times
was read the article

2585

Total PDF

6485

Total HTML

Share statistics

Article information

ISSN: 20132514
Original language: English

DOI:10.1016/j.nefroe.2016.01.006

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	16	2	18
2025 5	103	62	165
2025 4	65	45	110
2025 3	102	49	151
2025 2	84	38	122
2025 1	46	34	80
2024 12	71	25	96
2024 11	57	55	112
2024 10	43	56	99
2024 9	55	27	82
2024 8	75	69	144
2024 7	52	31	83
2024 6	62	33	95
2024 5	83	31	114
2024 4	68	27	95
2024 3	55	30	85
2024 2	47	36	83
2024 1	46	23	69
2023 12	37	31	68
2023 11	39	34	73
2023 10	37	24	61
2023 9	56	27	83
2023 8	27	26	53
2023 7	28	23	51
2023 6	62	21	83
2023 5	65	27	92
2023 4	49	17	66
2023 3	73	21	94
2023 2	55	15	70
2023 1	32	27	59
2022 12	71	31	102
2022 11	43	22	65
2022 10	58	36	94
2022 9	42	34	76
2022 8	42	54	96
2022 7	26	51	77
2022 6	33	41	74
2022 5	42	26	68
2022 4	32	55	87
2022 3	44	42	86
2022 2	31	35	66
2022 1	44	36	80
2021 12	56	33	89
2021 11	38	39	77
2021 10	35	37	72
2021 9	24	34	58
2021 8	36	42	78
2021 7	50	36	86
2021 6	47	35	82
2021 5	32	39	71
2021 4	58	38	96
2021 3	31	29	60
2021 2	32	27	59
2021 1	29	15	44
2020 12	31	30	61
2020 11	32	14	46
2020 10	34	20	54
2020 9	28	15	43
2020 8	26	11	37
2020 7	43	17	60
2020 6	20	21	41
2020 5	27	9	36
2020 4	24	25	49
2020 3	25	15	40
2020 2	34	19	53
2020 1	26	19	45
2019 12	36	19	55
2019 11	24	27	51
2019 10	19	11	30
2019 9	13	11	24
2019 8	18	15	33
2019 7	18	21	39
2019 6	17	14	31
2019 5	16	16	32
2019 4	34	34	68
2019 3	31	14	45
2019 2	20	14	34
2019 1	29	13	42
2018 12	158	42	200
2018 11	354	14	368
2018 10	350	19	369
2018 9	157	16	173
2018 8	171	18	189
2018 7	93	14	107
2018 6	106	24	130
2018 5	174	12	186
2018 4	171	14	185
2018 3	205	10	215
2018 2	87	5	92
2018 1	119	9	128
2017 12	95	5	100
2017 11	62	13	75
2017 10	36	8	44
2017 9	24	6	30
2017 8	25	8	33
2017 7	22	6	28
2017 6	33	8	41
2017 5	41	10	51
2017 4	32	10	42
2017 3	26	7	33
2017 2	22	7	29
2017 1	24	8	32
2016 12	28	7	35
2016 11	36	16	52
2016 10	48	6	54
2016 9	75	2	77
2016 8	46	0	46
2016 7	125	4	129
2016 6	79	0	79
2016 5	118	0	118
2016 4	52	0	52

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter